Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHEVALIER, X.
Right arrow Articles by TYLER, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHEVALIER, X.
Right arrow Articles by TYLER, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology


other

PRODUCTION OF BINDING PROTEINS AND ROLE OF THE INSULIN-LIKE GROWTH FACTOR I BINDING PROTEIN 3 IN HUMAN ARTICULAR CARTILAGE EXPLANTS

X. CHEVALIER and J. A. TYLER

Strangeways Research Laboratory, Worts' Causeways Cambridge CB1 4RN

Correspondence to: Correspondence to: X. Chevalier, Service de Rhumatologie, Hôpital Henri-Mondor, Bd De Lattre de Tassigny, 94010 Creteil, France.

The aim of this study was to determine the production of insulin-like growth factor binding proteins (IGFBP) and the role of the IGFBP-3 in human normal (n = 2) and osteoarthritic (OA) articular cartilage (n = 14) explants. Binding proteins were studied in the medium by Western ligand blotting and Western blotting. Proteoglycan synthesis under insulin-like growth factor I (IGF-I) stimulation was studied after a pulse of 35SO2–4 in the presence or absence of added IGFBP-3. Osteoarthritic explants released a doublet of IGFBPs with a 39/43 kDa Mr corresponding to the binding protein 3. Constitutive production from unstimulatcd OA cartilage was higher than from normal cartilage. IGF-1 induced a 20-fold increase and IL-1 a 2-fold increase in IGFBP-3 release. A minor band around 30 kDa was also detectable. Studies of proteoglycan (PG) synthesis showed that the majority of OA cartilage explant samples responded weakly to IGF-I (100 ng/ml) stimulation (+33%), while the others were high responders (+180%). Co-incubation of IGF-I with recombinant (r) IGFBP-3 did not affect the rate of PG synthesis. However, while pre-incubation with rIGFBP3 for 72 h did not change the rate of PG synthesis in the high-responder group, it strongly increased PG synthesis in the low-responder group. This study demonstrates that the ability of IGF-I to enhance proteoglycan synthesis varied among the OA samples and may in part be dependent on the local level of IGFBP-3. This implies pathophysiological considerations in the limits of IGF-I action during the OA process.

KEY WORDS: Osteoarthritis, Insulin-like growth factor 1, Binding protein 3, Proteoglycan


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Sci Aging Knowl EnvironHome page
R. F. Loeser Jr.
Aging Cartilage and Osteoarthritis--What's the Link?
Sci. Aging Knowl. Environ., July 21, 2004; 2004(29): pe31 - pe31.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Okazaki, S. Jingushi, T. Ikenoue, K. Urabe, H. Sakai, A. Ohtsuru, K. Akino, S. Yamashita, S. Nomura, and Y. Iwamoto
Expression of Insulin-Like Growth Factor I Messenger Ribonucleic Acid in Developing Osteophytes in Murine Experimental Osteoarthritis and in Rats Inoculated with Growth Hormone-Secreting Tumor
Endocrinology, October 1, 1999; 140(10): 4821 - 4830.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Karas, M. Danilenko, D. Fishman, D. LeRoith, J. Levy, and Y. Sharoni
Membrane-associated Insulin-like Growth Factor-binding Protein-3 Inhibits Insulin-like Growth Factor-I-induced Insulin-like Growth Factor-I Receptor Signaling in Ishikawa Endometrial Cancer Cells
J. Biol. Chem., June 27, 1997; 272(26): 16514 - 16520.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.